RCKT: Rocket Pharmaceuticals, Inc. Company Short-Term Debt

Graphic logo of Rocket Pharmaceuticals, Inc. (RCKT)

Rocket Pharmaceuticals (RCKT) dominates the rare disease therapy segment, possessing exceptional pricing power over its unique medications. The business relies on the development of innovative DNA-based products to combat severe ailments. This chart reflects an asset value of 0.00, accompanying the preparation period for the first market launch of a drug for Danon disease and the expansion of production capacities.

RCKT (Rocket Pharmaceuticals, Inc.) Company Current Liabilities history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company Rocket Corp (RCKT)

- current quotes and average value forecast:
Price Chart Rocket Pharmaceuticals, Inc.|RCKT - Fair Value Consensus
- market capitalization information:
Market Value Rocket Pharmaceuticals, Inc.|RCKT - Total Enterprise Value
- shareholders' equity book value data:
Book Value per Share Rocket Pharmaceuticals|RCKT - Company Net Assets|Market Value to Book Value Ratio rocketpharma.com|RCKT - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Rocket Pharmaceuticals|RCKT - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Rocket Pharmaceuticals|RCKT - Company Cumulative Indebtedness|Debt to Book Value Rocket Pharmaceuticals, Inc.|RCKT - Company Long-Term Loans and Borrowings|Company Short-Term Debt Rocket Pharmaceuticals|Quick Ratio rocketpharma.com
- net income and valuation multiples indicators:
RCKT - Final Profit
Summary company analytics:Rocket Pharmaceuticals, Inc. - RCKT
Manufactured products of rocketpharma.com

The indicator is calculated by aggregating all liabilities with a maturity of up to one year, reflecting immediate liquidity. This metric separates short-term volatility from fundamental stability by capturing the current debt load. For Rocket Pharmaceuticals (RCKT), such payments are critical during reagent logistics disruptions or patent disputes. Analyzing total short-term liabilities allows for an assessment of access to capital. The trend in total short-term liabilities signals the stability of operational cash flows.

Competing companies

TEM - Company Short-Term Debt|Company Short-Term Loans and Borrowings QGEN (Qiagen NV)|Ionis Pharma (IONS) - Company Short-Term Debt|Short-Term Debt Repligen Inc. (RGEN)|RNA (Avidity Biosciences) - Company Short-Term Debts|Company Current Liabilities crisprtx.com (CRSP)|Company Short-Term Debt GeneDx (WGS)|Company Short-Term Debts Ultragenyx Pharmaceutical Inc. (RARE)|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Sarepta Corp (SRPT) - Short-Term Debt|TWST: Company Current Liabilities|10xgenomics.com - Amount of Current Liabilities|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt BioLife Corp|Wave Pharma - Current Liabilities|Company Short-Term Debts MAZE|SION (sionnatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PRME (Prime Medicine)|Company Short-Term Debts Taysha Gene Therapies Inc TSHA|QURE - Company Short-Term Debt|Company Short-Term Loans and Borrowings MGTX (MeiraGTx Corp)|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Company Current Liabilities solidbio.com|OCGN (Ocugen) - Company Short-Term Debts|Company Short-Term Debts Pacific Biosciences of California, Inc.|Company Short-Term Debts BNTC|Company Current Liabilities Design Corp DSGN|Company Short-Term Debts FDMT (4D Molecular Therapeutics)|Lexeo Therapeutics Inc. (LXEO) - Short-Term Debt|KRRO: Company Current Liabilities|EDIT - Company Short-Term Debts|SLN (Silence Therapeutics Inc.) - Company Current Liabilities|PRQR: Amount of Current Liabilities|CDXS (Codexis Inc) - Company Short-Term Debts|sangamo.com (SGMO) - Short-Term Debt Volume|Company Short-Term Debts NAUT|Company Current Liabilities Metagenomi Inc. MGX|Company Short-Term Debts DTIL (Precision BioSciences)|Company Short-Term Debts Generation Bio Co GBIO|BOLD - Company Short-Term Debt|XCUR: Company Short-Term Debt|imunon.com (IMNN) - Company Short-Term Debt|PHIO - Short-Term Debt Volume|Company Short-Term Debt Mustang Bio Inc|RNAZ: Company Short-Term Loans and Borrowings|Company Short-Term Debts BNGO|Company Current Liabilities adnas.com APDN|Company Short-Term Debt bluebird bio BLUE|Company Short-Term Debts ImmunoPrecise Antibodies Ltd IPA|OMGA: Company Current Liabilities|Singular Genomics Corp - Amount of Current Liabilities|RGLS: Company Short-Term Debts|Company Short-Term Indebtedness SYRS|Company Short-Term Debt Telesis Bio|Company Short-Term Indebtedness TCON (TRACON Pharmaceuticals Inc.)|Company Short-Term Debts UBX